Get the Stockscreener App
1.09
0.00%
0.00
After Hours:
1.08
-0.01
-0.92%
Cocrystal Pharma Inc stock is traded at $1.09, with a volume of 62,027.
It is up +0.00% in the last 24 hours and down -9.92% over the past month.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
See More
Previous Close:
$1.09
Open:
$1.11
24h Volume:
62,027
Relative Volume:
0.04
Market Cap:
$11.20M
Revenue:
-
Net Income/Loss:
$-17.93M
P/E Ratio:
-0.6158
EPS:
-1.77
Net Cash Flow:
$-14.28M
1W Performance:
-11.38%
1M Performance:
-9.92%
6M Performance:
-31.87%
1Y Performance:
-36.99%
1-Day Range:
$1.075
$1.13
1-Week Range:
$1.06
$1.24
52-Week Range:
$1.01
$3.26
Cocrystal Pharma Inc Stock (COCP) Company Profile
Name
Cocrystal Pharma Inc
Sector
Industry
Phone
(786) 459-1831
Address
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.09 | 14.21M | 0 | -17.93M | -14.28M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-20 | Initiated | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Stock (COCP) Latest News
Is Cocrystal Pharma Inc. stock attractive for long term wealth buildingJuly 2025 Sector Moves & Free Community Supported Trade Ideas - newser.com
Can machine learning forecast Cocrystal Pharma Inc. recoveryMarket Sentiment Review & Long-Term Growth Plans - newser.com
How Cocrystal Pharma Inc. (8CC) stock reacts to fiscal policiesJuly 2025 Analyst Calls & Verified Stock Trade Ideas - newser.com
How Cocrystal Pharma Inc. stock responds to policy changesJuly 2025 Spike Watch & Stepwise Trade Signal Implementation - newser.com
Real time breakdown of Cocrystal Pharma Inc. stock performanceEarnings Miss & Weekly Breakout Stock Alerts - newser.com
Can Cocrystal Pharma Inc. stock maintain operating margins2025 Market Outlook & Risk Managed Investment Signals - newser.com
Is Cocrystal Pharma Inc. (8CC) stock among top earnings playsMarket Risk Analysis & Fast Moving Trade Plans - newser.com
Does Cocrystal Pharma Inc. show high probability of reboundWeekly Profit Analysis & Reliable Volume Spike Alerts - newser.com
Will Cocrystal Pharma Inc. stock pay special dividendsJuly 2025 Snapshot & Community Verified Trade Alerts - newser.com
Custom watchlist performance reports with Cocrystal Pharma Inc.July 2025 Short Interest & Proven Capital Preservation Methods - newser.com
Will Cocrystal Pharma Inc. stock beat EPS estimatesIPO Watch & Risk Controlled Swing Alerts - newser.com
How Cocrystal Pharma Inc. stock performs in rising dollar environment2025 Year in Review & Daily Stock Trend Reports - newser.com
Can Cocrystal Pharma Inc. hit a new high this monthEntry Point & Verified Short-Term Plans - newser.com
Does Cocrystal Pharma Inc. qualify in momentum factor screeningJuly 2025 Summary & High Yield Equity Trading Tips - newser.com
Is Cocrystal Pharma Inc. forming a reversal patternJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Why Cocrystal Pharma Inc. stock is considered a top pickJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com
Cocrystal Pharma, Inc. (COCP) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Statistical indicators supporting Cocrystal Pharma Inc.’s strengthTrade Volume Report & Consistent Profit Focused Trading Strategies - newser.com
What drives Cocrystal Pharma Inc 8CC stock priceMACD Histogram Signals & Small Capital Portfolio Tips - earlytimes.in
Cocrystal Pharma raises $1.03 million in private placement from directors By Investing.com - Investing.com Nigeria
Cocrystal Pharma Completes $1.03M Private Placement - MSN
Insider: Frost adds COCP stock, warrants at $1.39 unit, $1.24 strike - Stock Titan
[Form 4] Cocrystal Pharma, Inc. Insider Trading Activity - Stock Titan
COCP officer adds shares and warrants in 10/28/2025 trade - Stock Titan
Cocrystal Pharma, Inc. announced that it has received $1.032803 million in funding - MarketScreener
Cocrystal Pharma Inc (8CC.MU) stock price, news, quote and history - Yahoo! Finance UK
Cocrystal Pharma Inc Stock (COCP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):